0001415889-24-022859.txt : 20240904 0001415889-24-022859.hdr.sgml : 20240904 20240904205155 ACCESSION NUMBER: 0001415889-24-022859 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240901 FILED AS OF DATE: 20240904 DATE AS OF CHANGE: 20240904 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ragosa Mark CENTRAL INDEX KEY: 0001835458 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38492 FILM NUMBER: 241279463 MAIL ADDRESS: STREET 1: C/O KINIKSA PHARMACEUTICALS CORP. STREET 2: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals International, plc CENTRAL INDEX KEY: 0001730430 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 23 OLD BOND STREET, FLOOR 3 CITY: LONDON STATE: X0 ZIP: WIS 4PZ BUSINESS PHONE: 7814319100 MAIL ADDRESS: STREET 1: 23 OLD BOND STREET, FLOOR 3 CITY: LONDON STATE: X0 ZIP: WIS 4PZ FORMER COMPANY: FORMER CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd. DATE OF NAME CHANGE: 20180205 4 1 form4-09052024_120941.xml X0508 4 2024-09-01 0001730430 Kiniksa Pharmaceuticals International, plc KNSA 0001835458 Ragosa Mark 23 OLD BOND STREET, THIRD FLOOR LONDON X0 W1S 4PZ UNITED KINGDOM false true false false CHIEF FINANCIAL OFFICER 0 Class A Ordinary Share 2024-09-01 4 M 0 4444 A 24313 D Class A Ordinary Share 2024-09-01 4 F 0 2260 26.74 D 22053 D Class A Ordinary Share 2024-09-02 4 M 0 1861 A 23914 D Class A Ordinary Share 2024-09-02 4 F 0 956 26.74 D 22958 D Restricted Share Unit 2024-09-01 4 A 0 6365 0 A Class A Ordinary Share 6365 6365 D Share Option 26.74 2024-09-01 4 A 0 33150 0 A 2034-08-31 Class A Ordinary Share 33150 33150 D Restricted Share Unit 2024-09-01 4 M 0 2694 0 D Class A Ordinary Share 2694 5388 D Restricted Share Unit 2024-09-01 4 M 0 1750 0 D Class A Ordinary Share 1750 5250 D Restricted Share Unit 2024-09-02 4 M 0 1861 0 D Class A Ordinary Share 1861 1861 D Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2024. The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2024. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021. /s/ Madelyn Zeylikman, Attorney-in-Fact 2024-09-04